EXC Stock Analysis: Exelon | NASDAQ
Utilities - Regulated Electric | NASDAQ, USA | Market Cap: 47.247m USD | 12M Return: 4% | US30161N1019 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 328M
EPS Trend: 94.1%
Qual. Beats: 0
Rev. Trend: 98.5%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Exelon Corporation (NASDAQ: EXC) is a U.S. utility services holding company headquartered in Chicago, Illinois. It operates regulated energy distribution and transmission businesses, purchasing and selling electricity and natural gas at retail to residential, commercial, industrial, public-authority, and electric-railroad customers across multiple states.
As a regulated electric utility, Exelons earnings are largely shaped by rate-base investments and the rates of return authorized by state public utility commissions, which tend to produce stable cash flows relative to unregulated power generators. The company was incorporated in 1999 and trades as a large-cap stock within the Utilities sector.
- Illinois rate case decisions impact ComEd allowed returns
- Interest rate hikes pressure utility borrowing costs
- Data center load growth boosts transmission investment demand
| Net Income: 2.78b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.02 > 0.02 and ΔFCF/TA -0.00 > 1.0 |
| NWC/Revenue: -0.03% < 20% (prev -2.02%; Δ 1.99% < -1%) |
| CFO/TA 0.06 > 3% & CFO 7.21b > Net Income 2.78b |
| Net Debt (51.0b) to EBITDA (9.06b): 5.63 < 3 |
| Current Ratio: 1.00 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.03b) vs 12m ago 2.54% < -2% |
| Gross Margin: 24.54% > 18% (prev 41.82%; Δ -17.28% > 0.5%) |
| Asset Turnover: 21.87% > 50% (prev 21.38%; Δ 0.48% > 0%) |
| Interest Coverage Ratio: 2.40 > 6 (EBIT TTM 5.30b / Interest Expense TTM 2.21b) |
| A: -0.00 (Total Current Assets 9.00b - Total Current Liabilities 9.01b) / Total Assets 121b |
| B: 0.07 (Retained Earnings 8.03b / Total Assets 121b) |
| C: 0.05 (EBIT TTM 5.30b / Avg Total Assets 116b) |
| D: 0.33 (Book Value of Equity 29.7b / Total Liabilities 90.8b) |
| Altman-Z'' = 0.87 = B |
| DSRI: 1.05 (Receivables 4.60b/4.11b, Revenue 25.3b/23.8b) |
| GMI: 1.70 (GM 41.82% / 24.54%) |
| AQI: 0.97 (AQ_t 0.19 / AQ_t-1 0.20) |
| SGI: 1.07 (Revenue 25.3b / 23.8b) |
| TATA: -0.04 (NI 2.78b - CFO 7.21b) / TA 121b) |
| Beneish M = -2.32 (Cap -4..+1) = BBB |
As of August 20, 2026, the stock is trading at USD 45.30 with a total of 3,722,908 shares traded. Over the past week, the price has changed by +0.18%, over one month by -1.44%, over three months by +2.48% and over the past year by +3.98%.
Current recommended Stop Loss: 44.00 (which is 2.9% or 1.4 ATR below the current price).
Exelon has received a consensus analysts rating of 3.33. Therefore, it is recommended to hold EXC.
- StrongBuy: 4
- Buy: 2
- Hold: 9
- Sell: 2
- StrongSell: 1
| Analysts Target Price | 49.2 | 8.6% |
P/E Trailing = 16.8603
P/E Forward = 16.1031
P/S = 1.8656
P/B = 1.5909
P/EG = 2.6379
Revenue TTM = 25.3b USD
EBIT TTM = 5.30b USD
EBITDA TTM = 9.06b USD
Long Term Debt = 50.7b USD (from longTermDebt, last quarter)
Short Term Debt = 1.97b USD (from shortTermDebt, last quarter)
Debt = 52.3b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 51.0b USD (calculated: Debt 52.3b - CCE 1.25b)
Enterprise Value = 98.3b USD (47.2b + Debt 52.3b - CCE 1.25b)
Interest Coverage Ratio = 2.40 (Ebit TTM 5.30b / Interest Expense TTM 2.21b)
EV/FCF = -51.29x (Enterprise Value 98.3b / FCF TTM -1.92b)
FCF Yield = -1.95% (FCF TTM -1.92b / Enterprise Value 98.3b)
FCF Margin = -7.57% (FCF TTM -1.92b / Revenue TTM 25.3b)
Net Margin = 10.99% (Net Income TTM 2.78b / Revenue TTM 25.3b)
Gross Margin = 24.54% ((Revenue TTM 25.3b - Cost of Revenue TTM 19.1b) / Revenue TTM)
Gross Margin QoQ = 41.04% (prev 28.28%)
Tobins Q-Ratio = 0.82 (Enterprise Value 98.3b / Total Assets 121b)
Interest Expense / Debt = 4.23% (Interest Expense 2.21b / Debt 52.3b)
Taxrate = 17.29% (582.0m / 3.37b)
NOPAT = 4.38b (EBIT 5.30b * (1 - 17.29%))
Current Ratio = 1.00 (Total Current Assets 9.00b / Total Current Liabilities 9.01b)
Debt / Equity = 1.76 (Debt 52.3b / totalStockholderEquity, last quarter 29.7b)
Debt / EBITDA = 5.63 (Net Debt 51.0b / EBITDA 9.06b)
Debt / FCF = -26.64 (negative FCF - burning cash) (Net Debt 51.0b / FCF TTM -1.92b)
Total Stockholder Equity = 29.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.40% (Net Income 2.78b / Total Assets 121b)
RoE = 9.61% (Net Income TTM 2.78b / Total Stockholder Equity 29.0b)
RoCE = 6.65% (EBIT 5.30b / Capital Employed (Equity 29.0b + L.T.Debt 50.7b))
RoIC = 3.91% (NOPAT 4.38b / Invested Capital 112b)
WACC = 4.05% (E(47.2b)/V(99.5b) * Re(4.66%) + D(52.3b)/V(99.5b) * Rd(4.23%) * (1-Tc(0.17)))
Discount Rate = 4.66% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 88.65 | Cagr: 1.19%
[DCF] Fair Price = unknown (Cash Flow -1.92b)
EPS Correlation: 94.14 | EPS CAGR: 8.80% | SUE: 0.0 | # QB: 0
Revenue Correlation: 98.54 | Revenue CAGR: 6.23% | SUE: 3.25 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.83 | Chg30d=-5.41% | Revisions=-36% | Analysts=11
EPS current Year (2026-12-31): EPS=2.85 | Chg30d=-0.11% | Revisions=+0% | GrowthEPS=+3.0% | GrowthRev=+4.7%
EPS next Year (2027-12-31): EPS=3.03 | Chg30d=-0.17% | Revisions=-10% | GrowthEPS=+6.3% | GrowthRev=+3.3%
[Analyst] Revisions Ratio: -19% (up=9, down=14)